News
SCORR Agency of Record for Xcelience
Xcelience, an early development contract research organization focused on formulation development, pre-formulation services, analytical services, and clinical trial manufacturing, has selected SCORR Marketing of Kearney, Nebraska, as its agency of record. Under the agreement, SCORR will develop and implement Xcelience’s strategic marketing plan, brand development, public relations, media management, and tradeshow coordination.
“We are pleased to be working with Xcelience as they continue to grow,” said Cinda Orr, owner and president of SCORR Marketing. “We have a major focus in the pharmaceutical industry and the strong leadership of Xcelience’s management promises big things for their future. We are glad to become one of their partners.”
As the industry expert in formulation development, Xcelience has earned a solid reputation of accelerating early development activities to speed potential drugs to clinical trials while applying unparalleled scientific knowledge and experience. Xcelience is based in Tampa, Florida. “SCORR is an industry expert for marketing CRO and drug development companies,” states Randall Guthrie, Xcelience vice president. “We have already been impressed with their strategic insight and creativity— they will set the stage for the next level of growth for Xcelience.”
SCORR Marketing is a full-service marketing and public relations firm offering complete strategic communications programs to clients in a wide variety of markets and industries. For more information or to view samples of their work, visit online at www.scorrmarketing.com, or call 308.237.5567.
About Xcelience
Xcelience is the premier source for unsurpassed quality in drug development services. The company brings together the industry’s most experienced and talented scientists, consistently and efficiently moving compounds through the research and development continuum to regulatory approval.
Since 1997, the Tampa-based laboratory has been developing formulations for clients throughout the pharmaceutical industry. Xcelience’s unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the Xcelience lab. The lab uses only state-of-the-art equipment, highlighted by the patented Xcelodose® which fills API directly to capsules (Xcelodose is a registered trademark of Capsugel BVBA). This and other technologies give Xcelience unparalleled speed to market without compromising its absolute commitment to quality.